Intensive lipid - lowering therapy is highly cost effective in patients with ST - elevation myocardial infarction: a two - year follow - up of Jena auf Ziel

1 September 2024 (17:00 - 17:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Franz Haertel

University hospital Jena, Jena (Germany)

9 More presentations in this session

Presentation thumbnail

Relationship between lipoprotein(a) and endogenous fibrinolytic status in patients with STEMI

Doctor J. Leader (Stevenage, GB)

Abstract Slides Video

Presentation thumbnail

The clinical characteristics and prognosis of patients with acute non-ST-segment elevation myocardial infarction complicated with impaired activity daily living

Professor K. Chen (Tianjin, CN)

Abstract Slides Video

Presentation thumbnail

ORBI risk score and inflammatory response in patients with acute ST-elevation myocardial infarction

Doctor J. Kunkel (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Combined activation of complement and coagulation is associated with myocardial injury in ST-elevation myocardial infarction

Mr K. Kluge (Oslo, NO)

Abstract Slides Video

Presentation thumbnail

Angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with STEMI: new kids on the block

Doctor G. Civieri (Padova, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Advancements in cardiovascular therapies for ST-elevation myocardial infarction: from molecular insights to clinical applications

The Event

Event poster

ESC Congress 2024

1 September 2024 17:00 CET

You may be interested in

Congress Session

Changing face of lipid-lowering therapy

Congress Session

Registries, observational, and other studies on lipids

Congress Presentation

Stepwise approach to lipid-lowering therapies: which one, when, and for whom?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources